Knowledge Distillery

The recent emergence of B.1.1.529, the Omicron variant has raised concerns for escape from protection by vaccines and therapeutic antibodies.

SARS-CoV-2 Omicron emerged in November 2021 and is rapidly spreading among the human population. While recent reports reveal that the Omicron variant…

The SARS-CoV-2 omicron variant of concern was identified in South Africa in November, 2021, and was associated with an increase in COVID-19 cases.

Neurological and neuroradiological manifestations in patients with COVID-19 have been extensively reported. Available imaging data are, however, very…

Platelets represent a potential therapeutic target for improved clinical outcomes in patients with COVID-19. The objective of this study was to…

There is an urgent need for an effective, oral, direct-acting therapeutic to block transmission of severe acute respiratory syndrome coronavirus 2…

Easy-to-administer anti–SARS-CoV-2 treatments may be used to prevent progression from asymptomatic infection to symptomatic disease and to reduce…

A range of safe and effective vaccines against SARS CoV 2 are needed to address the COVID 19 pandemic. In this article the authors aimed to assess the…

The inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac, Sinovac) has been widely used in a two-dose schedule. In this article the authors assessed…

The Ad26.COV2.S vaccine, which was approved as a single-shot immunization regimen, has been shown to be effective against severe coronavirus disease…

Few data exist on the comparative safety and immunogenicity of different COVID-19 vaccines given as a third (booster) dose. To generate data to…

Given the importance of flexible use of different COVID-19 vaccines within the same schedule to facilitate rapid deployment, the authors studied mixed…